CA3168005A1 — Liquid pharmaceutical composition of clonidine
Assigned to Rosemont Pharmaceuticals Ltd · Expires 2023-01-20 · 3y expired
What this patent protects
There is provided a liquid pharmaceutical composition suitable for oral administration comprising clonidine or a pharmaceutically acceptable salt thereof and at least one carrier agent to dissolve or substantially dissolve the clonidine or the pharmaceutically acceptable salt of …
USPTO Abstract
There is provided a liquid pharmaceutical composition suitable for oral administration comprising clonidine or a pharmaceutically acceptable salt thereof and at least one carrier agent to dissolve or substantially dissolve the clonidine or the pharmaceutically acceptable salt of clonidine therein. The pharmaceutical composition does not contain a buffer.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.